Clinical Trials Logo

Noncommunicable Diseases clinical trials

View clinical trials related to Noncommunicable Diseases.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06268002 Completed - Smoking Cessation Clinical Trials

Effect of Vernonia Cinerea Lozenges as a Smoking Cessation Aid in Patients With Non-communicable Diseases

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Vernonia cinerea is an herbal which has been recorded in many Thai herbal formulation and Thai traditional medicine has used this herbal for treating various diseases included hypertension, asthma, fever, hepatitis, kidney stone and smoking cessation. Now aday there are more interest for using Vernonia cinerea as a medication to aid smoker to quit smoking because it is cheaper than other current therapeutic medications. The objective of this study is to evaluate efficacy and safety of Vernonia cinerea lozenge for smoking cessation when compared to placebo.

NCT ID: NCT06133400 Completed - Microbiome Clinical Trials

Mapping the Health Status of the Population of French Polynesia: the MATAEA Project

MATAEA
Start date: November 4, 2019
Phase: N/A
Study type: Interventional

This is a cross-sectional study carried out on a sample of the adult population aged 18 to 69, distributed over the five archipelagos of French Polynesia. Participation in the study involves: agreement to answer a questionnaire to collect information on socio-demographic characteristics, lifestyle habits and medical history; physical measurements (height, weight, waist circumference, blood pressure and skin pigmentation); and agreement to take biological samples (blood, saliva and stool) for biological, genetic and microbiological analyses. The aim of the study is to assess the current health status of the population of French Polynesia and to evaluate the influence of contextual risk factors (lifestyle, place of residence, history of infection) and intrinsic susceptibility factors (genetics, age, gender, microbiota) in relation to non-communicable and infectious diseases.

NCT ID: NCT05880784 Completed - Clinical Audit Clinical Trials

PEN Implementation Study

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

There is a gap in the implementation of PEN services as well as in the monitoring and evaluation of the WHO PEN in Nepal. One reason for such gaps is due to a lack of team-based care in low-resource settings like Nepal. Both peer coaching and clinical audit have been shown to be cost-effective ways to improve NCD care. However, no data is available regarding its implementation and outcome. Besides, there is a lack of a proven module of peer coaching and clinical audit for effective NCD care implementation. To address this gap, the investigators designed an intervention to reinforce peer coaching and clinical audit practices in health facilities to improve WHO PEN implementation for better NCD management in Nepal. Aims of Implementation Research - To assess implementation outcomes (acceptability, adoption, feasibility, penetration, cost and sustainability) of onsite-peer coaching and clinical audit reinforcement intervention on PEN Program implementation at primary healthcare centers. - To evaluate the effectiveness of onsite-peer coaching and clinic audit reinforcement intervention in PEN program delivery at health facilities. - To identify barriers and enabling factors impacting the adoption of onsite-peer coaching and clinical audit in the implementation of the PEN program.

NCT ID: NCT05829642 Completed - Clinical trials for Non-communicable Diseases

Estonia's Enhanced Care Management Impact Evaluation

ECM
Start date: November 24, 2020
Phase:
Study type: Observational [Patient Registry]

Estonia's aging population faces an increasing burden of non-communicable diseases (NCDs) and a growing population suffers with multiple chronic conditions. These changes have reduced well-being and quality of life for many older Estonians, while increasing the use of high cost specialist and emergency care. In response, the Estonia Health Insurance Fund (EHIF) is working to support primary care physicians to improve care for complex patients with multiple chronic conditions. A new EHIF-led program, Enhanced Care Management (ECM), entails training family physicians to identify complex patients, co-develop proactive care plans with them, and to undertake more active outreach to and management of these patients.

NCT ID: NCT05389540 Completed - Infections Clinical Trials

Rural South and Southeast Asia Household Health Survey

SEACTN-HHS
Start date: October 3, 2022
Phase:
Study type: Observational

A cross-sectional household survey with two-stage cluster-randomized sampling. This cross-sectional household survey design to recruit a random sample of households that is representative for each of the study sites. From the selected households, all consenting, household members will be included in the study. This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z

NCT ID: NCT05319327 Completed - Obesity Clinical Trials

Targeting DNA-methylation Fingerprints Linked to Ultra-Processed Foods Consumption to Prevent Non-communicable Diseases: the METHYL-UP Study

METHYL-UP
Start date: June 6, 2021
Phase: N/A
Study type: Interventional

Non-communicable diseases (NCD) are the main health challenge in industrialized countries. However, these diseases are preventable if an intervention based on lifestyle is implemented at the population level. Diet has a great impact on the onset and progression of NCD. In this regard, ultra-processed food (UPF) consumption has been related to higher morbidity and mortality. UPF are defined as "formulations made mostly or entirely from substances derived from foods and additives, with little if any intact unprocessed or minimally processed foods" (NOVA definition). UPF are rich in saturated fats and additives and poor in fiber other nutrients. UPF consumption has raised in the last decades in the industrialized countries and this increase has been associated with higher prevalence of metabolic disorders such as diabetes, obesity, metabolic syndrome, cardiovascular disease, and cancer. However, mechanisms that link UPF consumption with NCD are poorly understood and clinical trials are needed to unravel these mechanisms and how to impact on them through lifestyle interventions. The investigators have previously identified DNA methylation marks associated with UPF consumption. DNA methylation marks are modifiable. The aim of the study is to assay if DNA methylation marks related to UPF consumption are reversible by reducing UPF consumption in a population of adults with overweight or obesity and with a high basal UPF consumption (>35% of total food consumption in g/day).

NCT ID: NCT05264792 Completed - Depression Clinical Trials

Remote Coaching for Supporting the Implementation of Depression Care in Primary Care in Rural India

ESSENCE-IT
Start date: October 6, 2022
Phase: N/A
Study type: Interventional

This cluster-randomized hybrid type-II implementation superiority trial will include 14 rural primary care facilities in Madhya Pradesh, which will implement a collaborative depression care packaged based on the WHO mhGAP program. These 14 facilities will be randomized to receive either 'Enhanced Implementation Support' or the existing 'Routine Implementation Support' control condition to determine if Enhanced Implementation Support is superior to Routine Implementation Support for ensuring successful implementation of the depression care package. Enhanced Implementation Support consists of remote coaching support and technical assistance. The primary implementation outcome is the proportion of outpatients screened on the PHQ-2 by facility staff. Secondary implementation outcomes will also be collected, including the number of depression cases identified, number of patients with depression referred to the medical officer, number of patients referred to an accepted treatment intervention (i.e., either antidepressant medication or brief psychological intervention), and number of patients who successfully complete treatment at follow up. Secondary patient outcomes will also be collected from patients enrolled in each arm. Patient-level outcomes include the proportion of patients who achieve remission (defined as PHQ-9<5) at 3-month follow up. Additional patient-level outcomes include symptoms of anxiety and functioning. This trial will develop and test an Enhanced Implementation Support strategy for integrating evidence-based mental health services into primary care facilities. Findings from the trial will inform the need to have external coaching for primary care facilities to meet their depression screening and treatment goals, or if they can achieve these goals via routine system support. This is crucial to inform policymakers, due to severe constraints on mental health budgets for programs in India. Findings can generate insights to inform the scale-up of depression care across other districts in Madhya Pradesh and in India.

NCT ID: NCT05182762 Completed - Colorectal Cancer Clinical Trials

Measuring Quality in Colorectal Cancer Surgery in Low- and Middle-income Countries

Start date: February 1, 2020
Phase:
Study type: Observational

To test the applicability of the Clavien-Dindo Classification (CDC) in an LMIC setting and to compare the prevalence and severity of complications in patients <60 and ≥60 years of age a retrospective medical records review is used.

NCT ID: NCT05176574 Completed - Clinical trials for Physicians' Perceptions on Physical Activity and Exercise for Health

Physicians' Perceptions on Physical Activity and Exercise in Non Communicable Diseases.

Start date: January 10, 2022
Phase:
Study type: Observational

This descriptive, cross sectional study aims to investigate the knowledge, attitudes, intentions, abilities, and behavior of physicians who manage patients with chronic, non-communicable, diseases about physical activity and exercise. The sample will be nationwide and consisted of about 20.350 physicians of all the 13 Greek Regions. An anonymous, coded and self- administered questionnaire will be used as the main research tool for measuring the knowledge, attitudes, intentions, abilities and behavior of physicians. The questionnaire will be developed via the Delphi method after a systematic literature review and a focus group. The construction of the main questionnaire via the Delphi method, will include 2-3 quantitative rounds of data collection by 16 experts. The experts, who will be physicians and have knowledge and experience in matters related to physical activity, exercise and chronic diseases, will be selected based on specific criteria. Once the questionnaire has been developed, it will be piloted on a sample of approximately 40-50 physicians - different from that of the study. Then it will be sent to the physicians of the main study. Beside the main questionnaire, the Greek Edition of International Physical Activity Assessment Questionnaire (International Physical Activity Questionnaire-Short, IPAQ), will be also provided to the physicians to evaluate their levels of physical activity. Both the questionnaires will be completed online, via electronic form (google), because of the Covid-19 pandemic. The questionnaires and the information letter will be sent electronically to the participants through the Panhellenic Medical Association. This study has been approved by the Bioethics and Ethics Committee of the School of Medicine of National and Kapodistrian University of Athens.

NCT ID: NCT05122832 Completed - Clinical trials for Non-Communicable Chronic Diseases

Prevalence of NCD Risk Factors in Kazakhstan

Start date: October 23, 2021
Phase:
Study type: Observational

This is a cross-sectional study that aims to study the prevalence of risk factors of noncommunicable diseases in people aged 18 to 69 years using the standardized and adopted STEPS questionnaire in the Republic of Kazakhstan.